Significance of Paroxysmal Atrial Fibrillation Complicating Acute Myocardial Infarction in the Thrombolytic Era

Background —Paroxysmal atrial fibrillation (PAF) is considered a frequent complication of acute myocardial infarction (AMI), associated with increased in-hospital and long-term mortality rates. This notion is based on data collected before thrombolysis and additional modern methods of treatment became widely available, and no information is available on the significance of PAF in the general population with AMI in the thrombolytic era. The aim of the present study was to define the incidence, associated clinical parameters, and short- and long-term prognostic significance of PAF in patients with AMI in the thrombolytic era. Methods and Results —A prospective, nationwide survey was conducted of 2866 consecutive patients admitted with AMI in all 25 coronary care units in Israel during January/February 1992, 1994, and 1996 (thrombolytic era [TE]). The data were compared with a previous Israeli study of 5803 patients with AMI hospitalized in 1981 through 1983 (prethrombolytic era [PTE]). Patients in the TE with PAF were older and had a worse risk profile than those without PAF. PAF in the TE was independently associated with increased 30-day (odds ratio, 1.32; 95% confidence interval, 0.92 to 1.87) and 1-year (relative risk, 1.33; 95% confidence interval, 1.05 to 1.68) mortality rates. The incidence of PAF (8.9% and 9.9%) and the 30-day (25.1% and 27.6%) and 1-year (38.4% and 42.5%) mortality rates of patients with PAF were similar in the TE and PTE, although PAF in the TE occurred in older and sicker patients than those in the PTE. After adjustment for conventional risk factors, PAF was associated with significantly lower 30-day (odds ratio, 0.64; 95% confidence interval, 0.44 to 0.94) and 1-year (relative risk, 0.69; 95% confidence interval, 0.54 to 0.88) mortality rates compared with the PTE. Conclusions —Patients with AMI who develop PAF in the TE have significantly worse short- and long-term prognoses than patients without PAF, mostly due to their worse risk profile. After adjustment for confounding factors, patients with PAF in the TE have a better overall outcome than counterparts in the PTE, probably reflecting the better management of patients with AMI in the TE.

[1]  V. Boyko,et al.  Usefulness of the Killip classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s. Israeli Thrombolytic Survey Group and the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. , 1997, The American journal of cardiology.

[2]  U. Goldbourt,et al.  Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes , 1997 .

[3]  U. Goldbourt,et al.  Improved Outcome of Elderly Patients (≥75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel , 1997 .

[4]  W. Stevenson,et al.  Improving survival for patients with atrial fibrillation and advanced heart failure. , 1996, Journal of the American College of Cardiology.

[5]  J. Madias,et al.  Atrial fibrillation in acute myocardial infarction: A prospective study based on data from a consecutive series of patients admitted to the coronary care unit , 1996, Clinical cardiology.

[6]  M. Flather,et al.  ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. , 1995, Circulation.

[7]  N. Ammash,et al.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy , 1995 .

[8]  S. Yusuf,et al.  Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.

[9]  R. M. Rubison,et al.  Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.

[10]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.

[11]  M. Allessie,et al.  High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[12]  D. Singer,et al.  The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study. , 1992, American heart journal.

[13]  J. Halperin,et al.  Thromboembolism in nonvalvular atrial fibrillation: the answer may be in the ventricle. , 1992, International journal of cardiology.

[14]  C. Palombo,et al.  Effect of a new multifactorial antihypertensive on heart morphology and function in mild to moderate essential arterial hypertension. , 1992, European heart journal.

[15]  U. Goldbourt,et al.  Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction , 1992 .

[16]  H. Sørensen,et al.  Reduced occurrence of atrial fibrillation in acute myocardial infarction treated with streptokinase. , 1991, European heart journal.

[17]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[18]  P. Greenland,et al.  In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. , 1991, Circulation.

[19]  J. Coulehan,et al.  Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. , 1990, American heart journal.

[20]  J. Alpert,et al.  Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. , 1990, American heart journal.

[21]  R. Colman.  Hemostasis and thrombosis: Basic principles and clinical practice , 1987 .

[22]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[23]  J. Knoke,et al.  Survival after recovery from acute myocardial infarction. Two and five year prognostic indices. , 1979, The American journal of medicine.

[24]  N. Cristal,et al.  Atrial fibrillation developing in the acute phase of myocardial infarction. Prognostic implications. , 1976, Chest.

[25]  M. Gueron,et al.  Supraventricular arrhythmias in acute myocardial infarction. Prognostic importance of clinical setting; mechanism of production. , 1975, Annals of internal medicine.

[26]  C. Helmers,et al.  Atrial fibrillation in acute myocardial infarction. , 2009, Acta medica Scandinavica.

[27]  D. Julian,et al.  DISTURBANCES OF RATE, RHYTHM AND CONDUCTION IN ACUTE MYOCARDIAL INFARCTION: A PROSPECTIVE STUDY OF 100 CONSECUTIVE UNSELECTED PATIENTS WITH THE AID OF ELECTROCARDIOGRAPHIC MONITORING. , 1964, The American journal of medicine.